The hospital pharmacist: An integral part of the hyperglycaemic management team

Journal of Clinical Pharmacy and Therapeutics

Volumn 34, Issue 6, 2009, Pages 613-621

  Szumita, P M ^a  

^a BCPS   (United States)

Author keywords

Glycaemic control; Hospital management; Hyperglycaemia; Pharmacist; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN;

BLOOD GLUCOSE MONITORING; CLINICAL PROTOCOL; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH STATUS; HEMOGLOBIN BLOOD LEVEL; HOSPITAL PATIENT; HOSPITAL PHARMACY; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE UNIT; MEDICAL DOCUMENTATION; MEDICATION THERAPY MANAGEMENT; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PARAMETER; PATIENT CARE; PATIENT EDUCATION; PATIENT IDENTIFICATION; PATIENT MONITORING; PHARMACIST; PRESCRIPTION; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; INSULIN; INTENSIVE CARE UNITS; PATIENT CARE TEAM; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE;

EID: 70450174233     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01040.x     Document Type: Review

References (56)

1. Levetan CS (2004) Effect of hyperglycemia on stroke outcomes. Endocrine Practice, 10 (Suppl 2 34 39.
2. Saint S, Kaufman SR, Rogers MA, Baker PD, Boyko EJ, Lipsky BA (2006) Risk factors for nosocomial urinary tract-related bacteremia: a case-control study. American Journal of Infection Control, 34, 401 407.
3. Hein MD (2004) Management of hyperglycemia in the hospitalized podiatric medical patient. Journal of the American Podiatric Medical Association, 94, 135 148.
4. Lepore G, Maglio ML, Cuni C et al. (2006) Poor glucose control in the year before admission as a powerful predictor of amputation in hospitalized patients with diabetic foot ulceration. Diabetes Care, 29, 1985.
5. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL (2002) Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? Journal of the American College of Cardiology, 40, 1748 1754.
6. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE (2002) Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. Journal of Clinical Endocrinology and Metabolism, 87, 978 982.
7. Merrill CT, Elixhauser A (2005) Hospitalization in the United States, 2002. HCUP Fact Book No. 6. AHRQ Publication No. 05-0056. Rockville, Md : Agency for Healthcare Research and Quality.
8. Elixhauser A, Yu K, Steiner C, Bierman AS (2000) Hospitalization in the United States, 1997. HCUP Fact Book No. 1. AHRQ Publication No. 00 - 0031. Rockville, Md : Agency for Healthcare Research and Quality.
9. Clement S, Braithwaite SS, Magee MF et al. (2004) Management of diabetes and hyperglycemia in hospitals. Diabetes Care, 27, 553 591.
10. Garber AJ (2006) New standards to reduce morbidity and mortality in hospitalized patients with diabetes. American Family Physician, 73, 591 594.
11. Ahmann AJ (2004) Inpatient management of hospitalized patients with type 2 diabetes. Current Diabetes Reports, 4, 346 351.
12. Younis E, Badheeb A, Ajlouni H, Kareem SA, Ajlouni K (2001) Prevalence of missed hyperglycaemia among Jordan University Hospital mortality discharges, 1995-97. East Mediterranean Health Journal, 7, 46 51.
13. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE (1998) Unrecognized diabetes among hospitalized patients. Diabetes Care, 21, 246 249.
14. Carral F, Olveira G, Aguilar M et al. (2003) Hospital discharge records under-report the prevalence of diabetes in inpatients. Diabetes Research and Clinical Practice, 59, 145 151.
15. Moghissi E (2004) Hospital management of diabetes: beyond the sliding scale. Cleveland Clinic Journal of Medicine, 71, 801 808.
16. Krinsley JS (2003) Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clinic Proceedings, 78, 1471 1478.
17. Pomposelli JJ, Baxter JK III., Babineau TJ et al. (1998) Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN Journal of Parenteral and Enteral Nutrition, 22, 77 81.
18. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL (1999) Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care, 22, 1408 1414.
19. Ahmann A (2004) Reduction of hospital costs and length of stay by good control of blood glucose levels. Endocrine Practice, 10 (Suppl 2 53 56.
20. Pittas AG, Siegel RD, Lau J (2006) Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials. JPEN Journal of Parenteral and Enteral Nutrition, 30, 164 172.
21. Malmberg K, Ryden L, Efendic S et al. (1995) Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. Journal of the American College of Cardiology, 26, 57 65.
22. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A (1999) Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Annals of Thoracic Surgery, 67, 352 360.
23. Van den Berghe G, Wouters P, Weekers F et al. (2001) Intensive insulin therapy in critically ill patients. New England Journal of Medicine, 345, 1359 1367.
24. Krinsley JS (2004) Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clinic Proceedings, 79, 992 1000.
25. ACE/ADA Task Force on Inpatient Diabetes (2006) American College of Endocrinology and American Diabetes Association Consensus Statement on Inpatient Diabetes and Glycemic Control: a call to action. Diabetes Care, 29, 1955 1962.
26. Greci LS, Kailasam M, Malkani S et al. (2003) Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care, 26, 1064 1068.
27. Donihi AC, Raval D, Saul M, Korytkowski MT, Devita MA (2006) Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocrine Practice, 12, 358 362.
28. Taylor D, Young C, Mohamed R, Paton C, Walwyn R (2005) Undiagnosed impaired fasting glucose and diabetes mellitus amongst inpatients receiving antipsychotic drugs. Journal of Psychopharmacolocy, 19, 182 186.
29. Garber AJ, Moghissi ES, Bransome ED Jr. et al. (2004) American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocrine Practice, 10, 77 82.
30. American Association of Clinical Endocrinologists (2007) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocrine Practice, 13, 4 68.
31. American Diabetes Association (2008) American Diabetes Association practice recommendations, 2008. Diabetes Care, 31, S1 S110.
32. Szumita PM, Anger K, Greenwood B, Pendergrass M (2007) Prevention and treatment of hyperglycemia in hospitalized patients. Pharmacy Times, April 2007, 110 120.
33. Scheuren L, Baetz B, Cawley MJ, Fitzpatrick R, Cachecho R (2006) Pharmacist designed and nursing-driven insulin infusion protocol to achieve and maintain glycemic control in critical care patients. Journal of Trauma Nursing, 13, 140 145.
34. Bode BW, Braithwaite SS, Steed RD, Davidson PC (2004) Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocrine Practice, 10 (Suppl 2 71 80.
35. American Society of Health-System Pharmacists (2007) Insulins. In : American Society of Health-System Pharmacists, ed. AHFS Drug Information 2007. Bethesda, MD : American Society of Health-System Pharmacists, 3140 3164.
36. Manning EH, Jackson L (2005) An evaluation of the timing between key insulin administration-related processes: the reasons why these processes happen when they do, and how to improve their timing. Australian Health Review, 29, 61 67.
37. Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A (2005) Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care, 28, 950 955.
38. Home P, Kurtzhals P (2006) Insulin detemir: from concept to clinical experience. Expert Opinion on Pharmacotherapy, 7, 325 343.
39. Mathieu C (2004) Can we reduce hypoglycaemia with insulin detemir? International Journal of Obesity, 28 (Suppl 2 S35 S40.
40. Goldberg PA (2006) Memoirs of a root canal salesman: the successful implementation of a hospital-wide intravenous insulin infusion protocol. Endocrine Practice, 12 (suppl 3 79 85.
41. Golightly LK, Jones MA, Hamamura DH, Stolpman NM, McDermott MT (2006) Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy. Pharmacotherapy, 26, 1421 1432.
42. Dilkhush D, Lannigan J, Pedroff T, Riddle A, Tittle M (2005) Insulin infusion protocol for critical care units. American Journal of Health-System Pharmacy, 62, 2260 2264.
43. Rea RS, Donihi AC, Bobeck M et al. (2007) Implementing an intravenous insulin infusion protocol in the intensive care unit. American Journal of Health-System Pharmacy, 64, 385 395.
44. Reynolds LR, Cook AM, Lewis DA et al. (2007) An institutional process to improve inpatient glycemic control. Quality Management in Health Care, 16, 239 249.
45. Anger KE, Szumita PM (2006) Barriers to glucose control in the intensive care unit. Pharmacotherapy, 26, 214 228.
46. Boyle PJ, Zrebiec J (2007) Management of diabetes-related hypoglycemia. Southern Medical Journal, 100, 183 194.
47. American Diabetes Association (2007) Insulin delivery. Diabetes Forecast 2007. Resource Guide, January (Suppl RG20 RG35.
48. Greenwood B, Szumita PM, Pendergrass M (2008) Conversion to insulin devices in the inpatient setting. American Journal of Health-System Pharmacy, 65, 698 699.
49. American Society of Health-System Pharmacists (2008) Professional practice recommendations for safe use of insulin in hospitals. Available at : http://www.ashp.org/s-ashp/docs/files/Safe-Use-of-Insulin.pdf.
50. Haase R, Russell S (2006) Improving diabetes care and outcomes in a rural primary care clinic. Joint Commission Journal on Quality and Patient Safety, 32, 246 252.
51. Riddle MC, Rosenstock J, Gerich J (2003) The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care, 26, 3080 3086.
52. Hermansen K, Davies M, Derezinski T, Ravn GM, Clauson P, Home P (2006) A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetes Care, 29, 1269 1274.
53. Austin MM, Haas L, Johnson T et al. (2006) Self-monitoring of blood glucose: benefits and utilization. Diabetes Educator, 32, 835 837.
54. Bergenstal RM, Gavin JR III. (2005) The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. American Journal of Medicine, 118, 1S 6S.
55. Braithwaite SS, Buie MM, Thompson CL et al. (2004) Hospital hypoglycemia: not only treatment but also prevention. Endocrine Practice, 10 (suppl 2 89 99.
56. Wheeler K, Crawford R, McAdams D et al. (2004) Inpatient to outpatient transfer of care in urban patients with diabetes: patterns and determinants of immediate postdischarge follow-up. Archives of Internal Medicine, 164, 447 453.